Firstly, following PEX10 knockdown, we supplemented with the ROS inhibitor NAC and observed a significant reduction in ROS levels produced by PEX10 knockdown in prostate cancer cells (Fig. S2C). This evidence concerns the gene PEX10 and prostate cancer.